Cargando…

Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study

BACKGROUND: The sore throat pain model has been conducted by different clinical investigators to demonstrate the efficacy of acute analgesic drugs in single-dose randomized clinical trials. The model used here was designed to study the multiple-dose safety and efficacy of lozenges containing flurbip...

Descripción completa

Detalles Bibliográficos
Autores principales: Schachtel, Bernard, Aspley, Sue, Shephard, Adrian, Shea, Timothy, Smith, Gary, Schachtel, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227086/
https://www.ncbi.nlm.nih.gov/pubmed/24988909
http://dx.doi.org/10.1186/1745-6215-15-263
_version_ 1782343732437188608
author Schachtel, Bernard
Aspley, Sue
Shephard, Adrian
Shea, Timothy
Smith, Gary
Schachtel, Emily
author_facet Schachtel, Bernard
Aspley, Sue
Shephard, Adrian
Shea, Timothy
Smith, Gary
Schachtel, Emily
author_sort Schachtel, Bernard
collection PubMed
description BACKGROUND: The sore throat pain model has been conducted by different clinical investigators to demonstrate the efficacy of acute analgesic drugs in single-dose randomized clinical trials. The model used here was designed to study the multiple-dose safety and efficacy of lozenges containing flurbiprofen at 8.75 mg. METHODS: Adults (n = 198) with moderate or severe acute sore throat and findings of pharyngitis on a Tonsillo-Pharyngitis Assessment (TPA) were randomly assigned to use either flurbiprofen 8.75 mg lozenges (n = 101) or matching placebo lozenges (n = 97) under double-blind conditions. Patients sucked one lozenge every three to six hours as needed, up to five lozenges per day, and rated symptoms on 100-mm scales: the Sore Throat Pain Intensity Scale (STPIS), the Difficulty Swallowing Scale (DSS), and the Swollen Throat Scale (SwoTS). RESULTS: Reductions in pain (lasting for three hours) and in difficulty swallowing and throat swelling (for four hours) were observed after a single dose of the flurbiprofen 8.75 mg lozenge (P <0.05 compared with placebo). After using multiple doses over 24 hours, flurbiprofen-treated patients experienced a 59% greater reduction in throat pain, 45% less difficulty swallowing, and 44% less throat swelling than placebo-treated patients (all P <0.01). There were no serious adverse events. CONCLUSIONS: Utilizing the sore throat pain model with multiple doses over 24 hours, flurbiprofen 8.75 mg lozenges were shown to be an effective, well-tolerated treatment for sore throat pain. Other pharmacologic actions (reduced difficulty swallowing and reduced throat swelling) and overall patient satisfaction from the flurbiprofen lozenges were also demonstrated in this multiple-dose implementation of the sore throat pain model. TRIAL REGISTRATION: This trial was registered with ClinicalTrials.gov, registration number: NCT01048866, registration date: January 13, 2010.
format Online
Article
Text
id pubmed-4227086
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42270862014-11-12 Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study Schachtel, Bernard Aspley, Sue Shephard, Adrian Shea, Timothy Smith, Gary Schachtel, Emily Trials Research BACKGROUND: The sore throat pain model has been conducted by different clinical investigators to demonstrate the efficacy of acute analgesic drugs in single-dose randomized clinical trials. The model used here was designed to study the multiple-dose safety and efficacy of lozenges containing flurbiprofen at 8.75 mg. METHODS: Adults (n = 198) with moderate or severe acute sore throat and findings of pharyngitis on a Tonsillo-Pharyngitis Assessment (TPA) were randomly assigned to use either flurbiprofen 8.75 mg lozenges (n = 101) or matching placebo lozenges (n = 97) under double-blind conditions. Patients sucked one lozenge every three to six hours as needed, up to five lozenges per day, and rated symptoms on 100-mm scales: the Sore Throat Pain Intensity Scale (STPIS), the Difficulty Swallowing Scale (DSS), and the Swollen Throat Scale (SwoTS). RESULTS: Reductions in pain (lasting for three hours) and in difficulty swallowing and throat swelling (for four hours) were observed after a single dose of the flurbiprofen 8.75 mg lozenge (P <0.05 compared with placebo). After using multiple doses over 24 hours, flurbiprofen-treated patients experienced a 59% greater reduction in throat pain, 45% less difficulty swallowing, and 44% less throat swelling than placebo-treated patients (all P <0.01). There were no serious adverse events. CONCLUSIONS: Utilizing the sore throat pain model with multiple doses over 24 hours, flurbiprofen 8.75 mg lozenges were shown to be an effective, well-tolerated treatment for sore throat pain. Other pharmacologic actions (reduced difficulty swallowing and reduced throat swelling) and overall patient satisfaction from the flurbiprofen lozenges were also demonstrated in this multiple-dose implementation of the sore throat pain model. TRIAL REGISTRATION: This trial was registered with ClinicalTrials.gov, registration number: NCT01048866, registration date: January 13, 2010. BioMed Central 2014-07-03 /pmc/articles/PMC4227086/ /pubmed/24988909 http://dx.doi.org/10.1186/1745-6215-15-263 Text en Copyright © 2014 Schachtel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Schachtel, Bernard
Aspley, Sue
Shephard, Adrian
Shea, Timothy
Smith, Gary
Schachtel, Emily
Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study
title Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study
title_full Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study
title_fullStr Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study
title_full_unstemmed Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study
title_short Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study
title_sort utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227086/
https://www.ncbi.nlm.nih.gov/pubmed/24988909
http://dx.doi.org/10.1186/1745-6215-15-263
work_keys_str_mv AT schachtelbernard utilityofthesorethroatpainmodelinamultipledoseassessmentoftheacuteanalgesicflurbiprofenarandomizedcontrolledstudy
AT aspleysue utilityofthesorethroatpainmodelinamultipledoseassessmentoftheacuteanalgesicflurbiprofenarandomizedcontrolledstudy
AT shephardadrian utilityofthesorethroatpainmodelinamultipledoseassessmentoftheacuteanalgesicflurbiprofenarandomizedcontrolledstudy
AT sheatimothy utilityofthesorethroatpainmodelinamultipledoseassessmentoftheacuteanalgesicflurbiprofenarandomizedcontrolledstudy
AT smithgary utilityofthesorethroatpainmodelinamultipledoseassessmentoftheacuteanalgesicflurbiprofenarandomizedcontrolledstudy
AT schachtelemily utilityofthesorethroatpainmodelinamultipledoseassessmentoftheacuteanalgesicflurbiprofenarandomizedcontrolledstudy